Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 1,000 | 0 |
| Gross Profit | N/A | N/A | N/A | 1,000 | N/A |
| Operating Expenses | 101,871 | 102,558 | 62,029 | 50,860 | 37,025 |
| Operating Income | -101,871 | -102,558 | -62,029 | -49,860 | -37,025 |
| Other Income | 13,278 | 12,587 | 2,042 | 210 | -2,733 |
| Pre-tax Income | -88,593 | -89,971 | -59,987 | -49,650 | -39,758 |
| Income Tax | 260 | 239 | 358 | 508 | 813 |
| Net Income Continuous | -88,853 | -90,210 | -60,345 | -50,158 | -40,571 |
| Minority Interests | N/A | N/A | N/A | N/A | -518 |
| Net Income | $-88,853 | $-90,210 | $-60,345 | $-50,158 | $-40,053 |
| EPS Basic Total Ops | -1.12 | -1.27 | -1.67 | -2.21 | -102.93 |
| EPS Basic Continuous Ops | -1.12 | -1.27 | -1.67 | -2.21 | -142.35 |
| EPS Diluted Total Ops | -1.12 | -1.27 | -1.67 | -2.21 | -102.93 |
| EPS Diluted Continuous Ops | -1.12 | -1.27 | -1.67 | -2.21 | -142.35 |
| EPS Diluted Before Non-Recurring Items | -1.12 | -1.27 | -1.67 | -2.21 | -102.93 |
| EBITDA(a) | $-100,975 | $-101,677 | $-60,916 | $-48,469 | $-36,594 |